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ClosurePercutaneous closure of septal defects is a successful treatment modality that has been used for a long period of
time in children.
Ourmain objective in this case report is to discuss the transcatheter closure of atrial and ventricular septal defects
of 4-month-old infant in the same session. As far as we know, this case is the smallest one in age that percutane-
ous VSD closure was done in the same session with ASD closure.
A 4-month-old boywith tachypnea, tachycardia diagnosed to have aneursymatic perimembranous ventricular sep-
tal defect (VSD) sized 4 mm and atrial septal defect (ASD) sized 8 mm. Anti-congestive treatment was started, but
despite to the treatment, his symptoms continued and hewas hospitalized 3 times for lower respiratory tract infec-
tions. Surgery was found as too risky because his lung parenchymawas not good and body weight was low. There-
fore, transcatheter closurewas planned. VSDwas closedwith 4 × 4 Amplatzer® Ductal Occluder II device, ASDwith
9 mm-sized Amplatzer® Septal Occluder. In his ﬁrst month control: his body weight increased to 6.2 kg.
In conclusion, percutaneous ASD, VSD closure is being done safely in children, but for the ﬁrst time, percutaneous
VSD closure was done in an infant with low body weight in the same session with ASD closure successfully. This
case will be an encouraging example for the future.
© 2015 The Society of Cardiovascular Academy. Production and hosting by Elsevier B.V. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Percutaneous closure of septal defects is a successful treatment
modality that has been used for a long period of time in children.
Our main objective in this case report is to discuss the transcatheter
closure of atrial and ventricular septal defects of a 4-month-old infant in
the same session. As far as we know, this case is the smallest one in age
that percutaneous VSD closure was done in the same session with ASD
closure, except hybrid procedures.Case report
A 4-month-old boy; weighing 4.6 kg, was referred to our clinic for the
heart murmur. He suffered from having frequent lower respiratory tract
infections. His weight gain was insufﬁcient. He had tachypnea (68/min),
tachycardia (150/min), and2–3°/6 pansystolicmurmur inhis physical ex-
amination. Aneurysmatic perimembranous ventricular septal defect
(VSD) sized 4 mm and atrial septal defect(ASD) sized 8 mm (Fig. 1)
were detected by transthoracic echocardiography. Anti-congestive treat-
ment was started, but despite the treatment, his symptoms continuedy, School of Medicine, Erciyes
mukcu).
diovascular Academy.
my. Production and hosting by Elseand he was hospitalized 3 times for lower respiratory tract infections.
Also, bilateral renal calculi were found in abdominal ultrasonography.
Surgical closureof septal defectswasplanned, but since the lungparen-
chymawas not good and his body weight was low, it was accepted as too
risky. Therefore, transcatheter closure was planned. Qp/Qs ratio was mea-
sured as 4, pulmonary artery pressure was 37/10 mean 29 mm Hg. VSD
was closed with 4 × 4 Amplatzer® Ductal Occluder II device, ASD with 9
mm-sized Amplatzer® Septal Occluder (Figs. 2, 3). The VSD was passed
through by using a right Judkins catheter or a partly cut pigtail catheter.
A hydrophilic glidewirewas passed across the defect into the right ventri-
cle and then into the pulmonary artery or superior vena cava,where itwas
snared andwithdrawn from the femoral vein thus establishing an arterio-
venous loop. Subsequently, a sheath was advanced to the left ventricle via
the arteriovenous circuit. An occluder was advanced into the delivery
sheath. Then the occluder was positioned on the VSD. Intervention was
guided transthoracic echocardiography in addition to ﬂoroscopy.
We have been following the patient for 1 year. We have seen him
ﬁrstly 1 week later on; 1 month, 3 months, 6 months after the proce-
dure. Each time we did his physical examination, checked his electro-
cardiogram, and controled valvular insufﬁciency and device position
with transthoracic echocardiography, we have not faced with any prob-
lem even the vascular ones. In his ﬁrst month control, his body weight
increased to 6.2 kg, his cardiac functions were normal, no residual
shunt was detected in echocardiographic examination. We also were
not faced with conduction problems like AV block.vier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND license
Fig. 3. Echocardiographic image of VSD after closure with ADO II device.
Fig. 1. Echocardiographic image of ASD.
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Large atrial septal defects may lead to congestive heart failure, fre-
quent respiratory infections, and growth retardation in infants.1
Also ventricular septal defects that have signiﬁcant shunt, increase
pulmonary blood ﬂow, enlarge the left chambers of heart, cause cardiac
dysfunction, arrhythmia and constitute a risk factor for infective
endocarditis.
Surgical closure of septal defects is gold standard, it is safe and effec-
tive; however, the morbidity associated with sternotomy/thoracotomy,
cardiopulmonary bypass, postoperative complications, and residual sur-
gical scarring cannot be avoided.
Transcatheter closure of perimembranous VSDs constitutes special
care because of greater technical difﬁculty arising from proximity to
the aortic valve and conduction tissue. In order to minimize such
risks; appropriate device should be selected according to the type, loca-
tion, and the size of the defect. Amplatzer®Ductal Occluder (ADO) is ac-
tually designed for ductal closure. As wementioned in previous studies,
shape of aneurysmatic VSD resembled PDA. Therefore, it makes closure
of VSDwith septal aneurysmpossiblewith theAmplatzer duct occluder.
The left ventricular margin of the VSD is larger than the right one. The
left ventricular margin resembles the aortic side and ampulla of a PDA
while the right ventricular margin and septal aneurysm resemble theFig. 2. Percutaneous Anarrowing of a PDA at the pulmonary artery margin.2 The design of
the ADO II device is soft in nature with no polyester material that does
not apply a direct force on conduction system. We have done 21 VSD
closures with ADO II device in 3 years interval in our institution. We
did not face with any complication and our success rate was 100%.
ADO II device are normally contraindicated in the patients less than
6 kg and less than 6months of age. But it is frequently used for PDA clo-
sure for newborns less than 6 kg. We have not faced with a case less
than 6 kg whose VSD was closed percutaneously in the literature.
New advances in pediatric cardiology enable us to apply interven-
tions safely and effectively to the younger patients even the newborn.
Interventions to multiple defects in the same session is a tough issue
in children.More commonusage of combined transcatheter procedures,
lessened the ratio of surgery needed cardiac lesions and decreased the
mortality and morbidity related to surgery. Mostly balloon angioplasty
or valvuloplasty were done with ASD, VSD, or PDA closure.3,4,5
We have only faced a single adult case whose VSD and ASD closed in
the same session percutaneously.6
In conclusion, percutaneous ASD, VSD closure is being done safely in
children, but for the ﬁrst time, percutaneous VSD closurewas done in an
infant with low body weight in the same session with ASD closure suc-
cessfully. This case will be an encouraging example for the future.SD, VSD closure.
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